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Cyclometalated cinchophen ligands on iridium(III):
towards water-soluble complexes with visible
luminescence†
Rebecca A. Smith, Emily C. Stokes, Emily E. Langdon-Jones, James A. Platts,
Benson M. Kariuki, Andrew J. Hallett* and Simon J. A. Pope*
Eight cationic heteroleptic iridium(III) complexes, [Ir(epqc)2(N^N)]
+, were prepared in high yield from a
cyclometalated iridium bridged-chloride dimer bearing two ethyl-2-phenylquinoline-4-carboxylate (epqc)
ligands. Two X-ray crystallographic studies were undertaken on selected complexes (where the ancillary
ligand N^N = 4,4’-dimethyl-2,2’-bipyridine and 4,7-diphenyl-1,10-phenanthroline) each conﬁrming the
proposed formulations, showing an octahedral coordination at Ir(III). In general, the complexes are lumi-
nescent (620–630 nm) with moderately long lifetimes indicative of phosphorescence. Hydrolysis of the
ethyl ester moieties of the epqc ligands gave the analogous cinchophen-based complexes, which were
water-soluble and visibly luminescent (568–631 nm). The spectroscopic and redox characterisation of the
complexes was complemented by DFT and TD-DFT calculations, supporting the assignment of dominant
3MLCT to the emissive character.
Introduction
There has been considerable attention and eﬀort disbursed
on iridium(III) complexes with cyclometalated ligands, due to
their tuneable and generally eﬃcient photoluminescence pro-
perties and subsequent performance in a variety of photo-
physical and electronic applications.1 Such complexes are
capable of showing intense phosphorescence at room temp-
erature;2 the heavy atom iridium centre mediating strong
spin–orbit coupling and intersystem crossing (ISC), mixing
the singlet and triplet excited states and generating high phos-
phorescent eﬃciencies. As a consequence, cyclometalated
iridium complexes have found many applications in a variety
of opto-electronically related applications, such as electro-
chemical cells,3 photovoltaics,4 and luminescence imaging.5
Their ability to perform in such roles relies upon an under-
standing of their excited state properties, which can be modu-
lated by altering the cyclometalating and/or ancillary ligand
associated with the iridium centre. The ability to tune
luminescence emission wavelengths through variation of
cyclometalating ligands and ancillary ligands (predominantly
for cationic complexes) renders such complexes very useful,
particularly in electrochemiluminescence (ECL).6 For example,
increasing the π-conjugation of phenylpyridine by adding an
aromatic ring (to give phenylquinoline) bathochromically
shifts the 3π–π* and triplet metal-to-ligand charge transfer
(3MLCT) emission due to lower lying π* orbitals.7 Conse-
quently, there have been several reports of phenylquinoline
derivatives as cyclometalating ligands with various ancillary
ligands.8 However, many applications of Ir(III) complexes in
this context, including biologically-related uses, require water
solubility. Surprisingly then, there have only been a handful
of reports of water-soluble iridium cyclometalated complexes,
most commonly where the ancillary diimine ligands are func-
tionalised with solubilising groups such as sugars,8j,l tria-
zoles,9 polyethyleneglycol (PEG),10 bioconjugates11 and
carboxylate groups,12 as well as the bis-cyclometalated bis-
aqua complexes;13 reports of water-solubilising fuctionalisa-
tion at the cyclometalating ligand are extremely rare.14 The
purpose of this paper is to present the synthesis and photo-
physical properties of a class of iridium complex that incor-
porate cyclometalated cinchophen-based ligands, providing a
convenient route towards water-soluble complexes with exploi-
table photophysical properties; the structural, spectroscopic,
electrochemical and photophysical studies are presented
together with supporting DFT and TD-DFT calculations on the
complexes.
†Electronic supplementary information (ESI) available: Data collection para-
meters for the crystallographic studies, electrochemical data for 3a–h, pictorial
representations of the calculated frontier orbitals for 3a–h and 4a–h and Carte-
sian coordinates obtained from DFT calculations. CCDC 907280 and 907282.
For ESI and crystallographic data in CIF or other electronic format see DOI:
10.1039/c3dt51098k
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Results and discussion
Synthesis and characterisation of the ligands and complexes
As an aside, it is noteworthy that many of the literature reports
on functionalised phenylquinoline compounds describe bio-
logical activities15 with applications as anti-malarial, anti-
inflammatory and antibacterial agents;16 ester-functionalised
phenylquinoline compounds have shown promise as amyloid
fibril17 and reverse transcriptase18 inhibitors. Ethyl-2-phenyl-
quinoline-4-carboxylate (epqcH) was prepared by simply dis-
solving and heating 2-phenylquinoline-4-carboxylic acid
(cinchophen) in ethanol with a few drops of conc. H2SO4. The
precursor iridium chloro-bridged dimer [(epqc)2Ir(µ-Cl)2Ir-
(epqc)2] (2) was synthesised according to established literature
conditions.19 Compound 2 readily reacted (Scheme 1) with a
range of selected diimine-type ligands in 2-methoxyethanol;
work-up and counter anion exchange yielded the crude mono-
metallic complexes, [Ir(epqc)2(N^N)]PF6 {N^N = 2,2′-bipyridine
(bpy) 3a; 4,4′-dimethyl-2,2′-bipyridine (dmbpy) 3b; 1,10-phe-
nanthroline (phen) 3d; 4,7-diphenyl-1,10-phenanthroline (dip)
3e; dipyrido[3,2-a:2′,3′-c]phenazine (dppz) 3f; benzo[i]dipyrido-
[3,2-a:2′,3′-c]phenazine (dppn) 3g; naphtha[2,3-a]dipyrido[3,2-
h:2′,3′-f ]phenazine-5,18-dione (qdppz) 3h}. For the reaction of
2 and diethyl-2,2′-bipyridine-4,4′-dicarboxylate (debpy), the
ethyl ester groups of bpy were selectively converted to 2-meth-
oxyethyl esters in situ, as informed by 1H NMR spectroscopy
and mass spectrometry therefore giving [Ir(epqc)2(dmbpc)]PF6
3c (dmbpc = di-2-methoxyethyl-2,2′-bipyridine-4,4′-dicarboxy-
late). It should be noted that the ethyl ester functionality of
the cyclometalated cinchophen ligand was retained in all
cases. Further purification for each complex was achieved
using column chromatography (silica; MeOH–CH2Cl2, 1 : 9)
with elution of the first red band and subsequent removal of
solvent giving the complexes as pure red-coloured powders in
good yields (>75%). The resultant complexes 3a–h were soluble
in a range of common organic solvents.
The conversion of complexes 3a–g to their corresponding
free acids was achieved by stirring the esterified complexes in
an equi-volume mixture of 1 M KOH and acetone under an
inert atmosphere. Subsequent neutralisation with 1 M HCl,
removal of solvent and extraction with methanol (allowing
removal of KCl) led to the isolation of complexes 4a–g as their
chloride salts, [Ir(pqca)2(N^N)]Cl. However,
1H NMR spec-
troscopy and mass spectrometry indicated that it was not possi-
ble to isolate 4h by this method, the reasons for which are
currently unknown.
All new complexes were characterised using a range of spec-
troscopic techniques. Firstly, the 1H NMR spectra of complexes
3a–h are complicated in the aromatic region with overlapping
resonances associated with the cyclometalated and diimine
ligands; the retention of the ethyl ester functionality was
observed in the aliphatic region. The 2-methoxyethyl groups of
3c appeared as broadened triplets at 4.46 and 3.68 ppm
together with a singlet at 3.30 ppm. 31P–{1H} NMR spec-
troscopy confirmed the presence of the PF6
− ion with a signa-
ture septet (1JPF) at ca. −145 ppm in all cases. Low and high
resolution mass spectra were obtained for the complexes 3a–h
and each confirmed the identity of the cationic, monomeric
species of type [(epqc)2Ir(N^N)]
+, revealing the parent cations
of [M − PF6]+ in each case, with the appropriate isotopic distri-
bution. Complex purity was confirmed by elemental analysis.
Upon hydrolysis of the ester groups, the 1H NMR spectra of
the isolated analogues 4a–g all confirmed the absence of the
ethyl, or 2-methoxyethyl groups in the case of 4c, yielding 2,2′-
bipyridyl-4,4′-dicarboxylic acid (bpdc), as well as improved
resolution of the aromatic resonances. The absence of a reso-
nance in the 31P–{1H} NMR spectra indicated the exchange of
PF6
− with Cl− counter ions in the deprotected species. The
Scheme 1 Synthetic route to complexes [Ir(epqc)2(N^N)]PF6 3a–h and [Ir(pqca)2(N^N)]Cl 4a–g.
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corresponding mass spectra were easily obtained: complexes
4a–g confirmed the identity of the cationic, monomeric
species of type [Ir(pqca)2(N^N)]
+ showing the characteristic
cluster of peaks associated with the [M − Cl]+ parent ion.
Solid-state IR spectra were also obtained on all complexes
highlighting the conversion from ester (ca. 1720 cm−1) to car-
boxylate (ca. 1580 cm−1) via significant low energy shifts in
ν(CvO), and the absence of the PF6
− counter ion stretch (ca.
835 cm−1) confirming exchange with chloride.
X-ray crystallography studies
Single crystals of 3b and 3e suitable for X-ray diﬀraction
studies were isolated following vapour diﬀusion of Et2O into
concentrated CHCl3 or MeCN solutions of the complexes, over
a period of 48 h at −20 °C. The bond lengths and bond angles
are reported in Table 1, and the associated data collection
parameters are reported in Table S1, ESI.†
The structures obtained for the three complexes (Fig. 1a
and 2a) confirmed the proposed formulations, and show that
the iridium(III) center in these [Ir(epqc)2(N^N)]
+ complexes
adopts a distorted octahedral coordination geometry. trans
Angles at the metal centers ranged from 168.0(3)° to 172.4(3)°
for 3b and 168.0(3)° to 174.9(3)° for 3e. The diimine ligand is
always coordinated trans to the cyclometalated phenyl rings;
the complexes retain the cis-C,C and trans-N,N chelating dis-
position of the original chloro-bridged dimer as reported in
related examples.7c,20 The trans-influence of the carbon
donors rendered slightly longer Ir–N bond lengths for the
diimine ligands {2.182(8) and 2.158(7) Å for 3b} than the epqc
ligands {2.094(8) and 2.112(8) Å for 3b}. The bite angles of the
epqc ligands (80.0(4)° and 80.3(4)° for 3b) were slightly larger
than that of N^N ligands {75.1(3) for 3b}. Similar observations
have been reported in related cyclometalated iridium(III) poly-
pyridine systems [Ir(pq)2(N^N)]
+.1e,7c,d,20 For 3e the structure
showed that the phenyl substituents of the 4,7-diphenyl-1,10-
phenanthroline ligand are twisted out of planarity from the
phenanthroline unit by 55.1° and 50.2° respectively. In
addition, as with related phenylquinoxaline complexes,7d,21
there is a distortion within the quinoline moiety caused by the
steric interactions between the chelating ligands (Fig. 1b and
2b). Some of the inter-ligand C⋯C and C⋯N non-bonding
contact distances (Table 1) are shorter than 3.4 Å (i.e. the sum
of the van der Waals radii of the atoms). This results in the
phenyl groups of the epqc ligand showing deformation angles
of 14.1° and 19.1° for 3b and 17.5° and 28.6° for 3e with
respect to the quinoline fragment of the ligand.
The bond lengths and angles of 3b and 3e were compared
with the optimised values calculated from density functional
theory (DFT) studies (also see DFT section and Table 1). In
general, a reasonable agreement was obtained between the
theoretical and experimentally observed bond lengths,
although some small diﬀerences were found. The calculated
Ir–Nbipyridine bond lengths, Ir–N(3) and Ir–N(4), are 0.038 and
0.062 Å longer than the experimental values for 3b. In the case
of the cyclometalated Ir–C bonds, calculated values are very
similar to the experimentally obtained data for Ir–C(1) in 3b
and 3e; similarly the Ir–Nquinoline bonds, where the calculated
and experimental values are comparable. Again, the calculated
structures reveal C⋯C and C⋯N interactions between the
ligands. The calculated deformation angles of the quinoline
fragment are much lower for 3b and 3e.
Density functional theory (DFT) studies
DFT calculations (computed using the B3PW91 hybrid func-
tional) were performed to investigate the frontier orbitals and
provide qualitative descriptions of the highest occupied
Fig. 1 (a) Ortep representation of [Ir(epqc)2(dmbpy)]
+ 3b (50% probability
ellipsoids, solvent molecules, PF6
− anion and hydrogen atoms have been
omitted for clarity) and (b) showing non-bonding contact interactions between
chelating ligands.
Fig. 2 (a) Ortep representation of [Ir(epqc)2(dip)]
+ 3e (50% probability ellip-
soids, solvent molecules, PF6
− anion and hydrogen atoms have been omitted for
clarity) and (b) showing non-bonding contact interactions between chelating
ligands.
Table 1 Selected bond lengths (Å) and angles (°) for complexes 3b and 3e
Bond length (Å)/
angle (°) 3b
Calculated
value 3e
Calculated
value
Ir(1)–N(1) 2.094(8) 2.107 2.078(6) 2.107
Ir(1)–N(2) 2.112(8) 2.107 2.107(7) 2.107
Ir(1)–N(3) 2.182(8) 2.220 2.190(6) 2.218
Ir(1)–N(4) 2.158(7) 2.220 2.153(7) 2.218
Ir(1)–C(1) 1.998(9) 1.997 1.989(8) 1.997
Ir(1)–C(19) 2.001(9) 1.997 2.005(8) 1.997
C(14)⋯N(3) 3.140a 3.127 3.009a 3.128
C(32)⋯N(4) 3.173a 3.128 3.232a 3.128
N(1)–Ir(1)–N(2) 170.7(3) 172.1 173.3(3) 172.8
N(1)–Ir(1)–C(1) 80.0(4) 80.0 79.4(5) 79.9
N(2)–Ir(1)–C(19) 80.3(3) 80.0 79.9(3) 79.9
C(1)–Ir(1)–C(19) 89.2(4) 90.1 88.6(3) 90.5
aNon-bonded metrics and those involving planes/centroids were not
included in the refinement, and thus do not have an e.s.d.
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molecular orbital (HOMO) and lowest unoccupied molecular
orbital (LUMO) energy levels.
For the [Ir(epqc)2(N^N)]
+ complexes, the energy levels of the
HOMO are suﬃciently diﬀerent (ΔE > 0.2 eV) from the other
MOs to be considered independent. In each case the HOMO
was located on the metal 5d(Ir) centre and cyclometalated
phenyl rings (Fig. S1, ESI†), with little or no coverage of the
ancillary diimine ligands. However, varying the diimine
ligands does impart a subtle perturbation of the HOMO
energy (EHOMO = −7.66 to −7.84 eV). The LUMO for the com-
plexes is, in many cases, close enough in energy to be con-
sidered isoenergetic with other close-lying MOs (e.g. LUMO +
1, LUMO + 2). For the complexes where this is not the case (3c,
3f, 3g and 3h), the LUMOs are predominantly delocalised over
the diimine ligands as with previous studies of related com-
pounds.7d For 3a, 3b, 3d and 3e the orbitals show a mixture of
diimine and phenylquinoline localisation. The diimine
imparts a larger degree of variation in the energy levels of the
LUMO energy (ELUMO = −4.71 to −5.47 eV), with 3h showing
the lowest LUMO energy level (ELUMO = −5.47 eV) and, there-
fore, smallest bandgap (Ebandgap = 2.29 eV). These results
suggest that the lowest energy absorption is predicted to com-
prise of significant MLCT character and that variation of the
diimine ligand could lead to a small degree of tuneable optical
properties within this series of complexes. The corresponding
cinchophen complexes (4a–h) showed the same general locali-
sation of the frontier orbitals, but revealed a drop in both the
HOMO and LUMO energies by an average of 0.12 eV and
0.13 eV, respectively (Fig. S2, ESI†).
Electrochemical studies
The electrochemical characteristics of the [Ir(epqc)2(N^N)]PF6
(3a–h) complexes were studied in de-oxygenated CH2Cl2. The
HOMO energy levels (EHOMO) were determined from the ioni-
sation potential of the first oxidation (Ir3+/4+) by direct corre-
lation with the redox couple of FeCp2
0/1+. The cyclic
voltammograms, measured at a platinum disc electrode (scan
rate υ = 200 mV s−1, 1 × 10−3 M solutions, 0.1 M [NBu4][PF6] as
a supporting electrolyte), each showed one non-fully reversible
oxidation (Table S2, ESI†), over the range +1.38 to +1.45 V. The
extent of the irreversibility can be ascribed to the contribution
of the cyclometalating ligands to the electron density of the
HOMO,22 which in this case is calculated to be ca. 45% from
DFT studies. The EHOMO values were determined using the
relevant equations23 and the resultant values fall in the narrow
range −5.72 to −5.83 eV (Table S3, ESI†). Each complex also
showed one or two partially reversible or irreversible reduction
waves, assigned to ligand-centred processes involving both the
diimine and phenylquinoline ligands, with complex 3h
showing at least four reduction processes, some of which must
be associated with the highly reducible anthraquinone
fragment.
Electronic properties of the complexes
The UV-vis absorption spectra of complexes 3a–h were
obtained as aerated MeCN solutions (5 × 10−5 M) (Fig. 3,
Table 3). Strong absorption bands between 250 and 380 nm
were assigned to spin allowed 1π–π* ligand-centered (LC) tran-
sitions arising from both the cyclometalated and diimine
ligands within each complex. Weaker bands at 380–480 nm in
the visible region were assigned to spin-allowed metal-to-
ligand charge transfer bands (1MLCT) with the possibility of
spin-forbidden 3MLCT transitions contributing to the weaker
low-energy shoulder. For 3h it is also likely that ligand-centred
transitions associated with the anthraquinone moiety also con-
tribute in this wavelength region; previous studies have shown
that such species can possess intra-ligand CT (formally n–π*)
character, which is likely to contribute to the lower energy
parts of the spectral profile. The variation in coordinated
diimine ligand imparts only a very minor variation in the wave-
length positioning of the visible absorption bands. As expected
the absorption spectra of the corresponding carboxylic acid
derivatives 4a–g (5 × 10−5 M MeOH) share many of the same
common features. The principal observation from these
spectra is that the visible MLCT-based bands appear as a
defined transition ca. 430–455 nm.
TD-DFT calculations (Table 2) in simulated MeCN suggest
the assignment of the lowest lying absorption bands as having
substantial MLCT character. For 3a the lowest energy absorp-
tion involves excitation from HOMO (Ir-5d + phenyl-π) to
LUMO + 1 (quinoline-π*), predicted to lie at 528 nm (oscillator
strength = 0.04 au), and so coincides reasonably closely with
the lowest energy shoulder feature seen in Fig. 4. A set of stron-
ger bands centred around 370 nm (387 nm, 0.15 au; 375 nm,
0.17 au; 359 nm, 0.10 au) is also predicted, again in good
agreement with Fig. 4. These bands consist of varying combi-
nations of Ir-5d and epqc-π orbitals excited into epqc-π* orbi-
tals, but have no contribution from the ancillary bpy-π*
orbitals. In comparison, TD-DFT simulation of 3c in MeCN
results in broadly the same pattern of predicted bands at
520 nm (0.04 au), 406 nm (0.06 au), 389 nm (0.07 au) and
384 nm (0.09 au), although the higher energy bands are
reduced in intensity relative to the low energy MLCT band. In
this complex, two low energy bands involving excitation from
HOMO (Ir 5d + phenyl-π) to LUMO and LUMO + 1 (bipy-π* and
quinoline-π*, respectively) are predicted at 564 and 522 nm,
Fig. 3 UV-vis spectra of selected [Ir(epqc)2(N^N)]PF6 complexes in MeCN
solutions (5 × 10−5 M).
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but with very low intensity (<0.001 au), suggesting the possi-
bility of MLCT/LLCT character.
Deprotection of the ester to yield complex 4a was modelled
using both the neutral acid and deprotonated carboxylate form.
In the neutral complex, calculations predict a red-shift of the
absorption bands discussed above by ca. 15 nm, and alteration
of the relative intensities of the absorptions, with predicted
bands lying at 544 nm (oscillator strength of 0.04 au), 394 nm
(0.12 au), 383 nm (0.15 au) and 365 nm (0.18 au). In contrast,
simulation of the deprotonated carboxylate form of 4a indicates
a substantial blue-shift of the absorption bands, with the lowest
energy absorption with significant oscillator strength coming at
456 nm (0.6 au), and a more intense band at 365 nm (0.12 au).
The latter approach is in much better agreement with the
experimental data, such that modelling 4a as the bis-carboxylate
form seems to be more appropriate.
Steady state luminescence measurements were conducted
on aerated MeCN solutions, irradiating the 1MLCT wavelength
(λex = 450 nm) absorption (Table 3, Fig. 4). The emission
maxima for complexes 3a–g show very little variation
(627–630 nm), are broad and featureless, and typically character-
istic of MLCT-based transitions.24 This variation is less than
that predicted by TD-DFT (see ESI†), possibly suggesting a
diminished diimine contribution to the excited state. Corres-
ponding excitation spectra showed that the complexes could
be excited up to a wavelength of ca. 520 nm. Time-resolved
emission lifetime measurements revealed that the decays were
single-exponential, in each case ca. 200 ns, typical of 3MLCT
character. The complexes each exhibited modest quantum
yields (Φ) in aerated MeCN, in line with related species. For
3h, the emission profile was very diﬀerent, with a higher
energy peak at 422 nm (τ < 5 ns), which was assigned to a
ligand-centred transition arising from the anthraquinone
chromophore, with no evidence of a comparable MLCT tran-
sition. The absence of 3MLCT emission is attributed to the
quenching of that state by the anthraquinone-based ancillary
ligand.
For ease of comparison the corresponding emission and
excitation of the deprotected complexes 4a–g were obtained in
MeCN, MeOH and water. With the exception of 4f these
species all showed a hypsochromic shift of ca. 50 nm in the
3MLCT emission maxima (Table 4). Similar measurements in
water resulted in an emission peak at ca. 595 nm, revealing the
solvent-sensitivity and dipolar nature of the excited state.
Emission wavelengths in methanol were typically intermediate
between those for water and acetonitrile (for example, Fig. 5).
Relative to the esterified analogues (3a–g), the measured
Fig. 4 Normalised luminescence emission spectra of selected [Ir(epqc)2(N^N)]-
PF6 complexes in MeCN solutions (5 × 10
−5 M).
Table 3 Photophysical properties of [Ir(epqc)2(N^N)]PF6 (3a–h) complexes
a
Complex λabs
a (nm) λem
a (nm) τa,b (ns) Φa
3a 470 (4500), 350 (22 000),
292 (39 500), 268 (45 650)
627 219 0.022
3b 467 (4200), 350 (23 500),
290 (46 500), 265 (55 300)
630 211 0.020
3c 464 (2850), 352 (18 150),
291 (39 500), 267 (47 850)
620 189 0.020
3d 460 (4500), 356 (25 750),
288 (52 750), 269 (65 350)
630 178 0.029
3e 465 (3550), 344 (23 300),
290 (55 950), 269 (59 000)
628 181 0.019
3f 463 (3650), 364 (29 700),
272 (82 550)
628 210 0.019
3g 461 (5450), 416 (12 100),
398 (13 550), 327 (58 600),
292 (51 900), 266 (68 200)
628 173 0.018
3h 460 (4550), 367 (29 500),
278 (83 750)
426 2.1 (57%),
<1 (43%)
—c
aMeCN solution. b λex = 459 nm.
cNot measured.
Table 2 Calculated excitation wavelengths for 3a and 4a from TD-DFT studies showing the dominant transitions
3a (ester) 4a (acid) 4a (carboxylate)
λa (nm) f b Character λ (nm) f Character λ (nm) f Character
528 0.0422 HOMO→ LUMO + 1 543 0.0348 HOMO→ LUMO + 1 456 0.056 HOMO→ LUMO
411 0.0538 HOMO − 1→ LUMO 420 0.0509 HOMO − 1→ LUMO 406 0.021 HOMO − 3→ LUMO
387 0.1495 HOMO − 2→ LUMO + 1 394 0.1245 HOMO − 2→ LUMO + 1 381 0.056 HOMO − 3→ LUMO + 1
385 0.0469 HOMO − 2→ LUMO 392 0.0421 HOMO − 2→ LUMO 366 0.115 HOMO − 6→ LUMO + 2
375 0.1743 HOMO − 3→ LUMO 383 0.1547 HOMO − 3→ LUMO 363 0.060 HOMO − 3→ LUMO + 3
359 0.1040 HOMO − 4→ LUMO 366 0.1732 HOMO − 4→ LUMO + 1 356 0.045 HOMO − 7→ LUMO + 1
HOMO − 4→ LUMO + 1
359 0.0815 HOMO − 4→ LUMO 364 0.0478 HOMO − 4→ LUMO 355 0.037 HOMO − 7→ LUMO + 2
HOMO − 4→ LUMO + 1 HOMO − 1→ LUMO + 2
a Excitation wavelength. bOscillator strength.
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lifetimes were generally extended for complexes 4a–g reflecting
the increased energy gap. However, in water the lifetime values
also varied greatly as a function of the type of diimine ligand,
with 4e (likely to be the most hydrophobic of the diimines in
this study) displaying the longest lifetime (τ = 619 ns),
suggesting greater shielding of the excited state from the sur-
rounding solvent.
The longer emission wavelength of 4f in all solvents
appears somewhat anomolous and could be due to a number
of factors. With reference to the TD-DFT calculations, the pro-
tonation state of the cinchophen ligands influences the emis-
sion wavelength. Repeating the measurement in 0.1 M NaOH
blue-shifted the emission peak to ca. 590 nm, in accordance
with the other complexes in the cinchophen-based series.
However, it is diﬃcult to rationalise why only 4f (versus 4g, for
example) would retain a protonated carboxylic acid form. An
alternative explanation considers the role of protonation at the
dppz ligand. The closely related species [Ir(ppy)2(dppz)]
+ 25
reveals λem = 630 nm in MeCN and is thus very comparable to
4f. However, H-bonding interactions with the phenazine nitro-
gens can dramatically influence the emission properties; in
fact, [Ir(ppy)2(dppz)]
+ is non-emissive in water, unlike 4f. The
reported photophysics of [Ir(ppy)2(dppn)]
+ 25 also compare very
well (λem = 583 nm in MeOH) to 4g, and thus the diﬀerences in
emission wavelength for 4f could be due to protonation inter-
actions at dppz26 (of course, these would also be sensitive to
the addition of 0.1 M NaOH).
Experimental section
All reactions were performed with the use of vacuum line and
Schlenk techniques. Reagents were commercial grade and
used without further purification. 1H and 13C–{1H} NMR
spectra were recorded on an NMR-FT Bruker 400 or 250 MHz
and 31P–{1H} NMR spectra on a Joel Eclipse 300 MHz spectro-
meter and recorded in CDCl3 or MeOD solutions.
1H and 13C–
{1H} NMR chemical shifts (δ) were determined relative to
internal tetramethylsilane, Si(CH3)4 and are given in ppm.
Low-resolution mass spectra were obtained by the staﬀ at
Cardiﬀ University. High-resolution mass spectra were carried
out at the EPSRC National Mass Spectrometry Service at
Swansea University, UK. UV-Vis studies were performed on a
Jasco V-650 spectrophotometer fitted with a Jasco temperature
control unit in MeCN or MeOH solutions (5 × 10−5 M) at 20 °C.
Photophysical data were obtained on a JobinYvon–Horiba
Fluorolog spectrometer fitted with a JY TBX picoseconds
photodetection module in MeCN, MeOH or H2O solutions.
Emission spectra were uncorrected and excitation spectra were
instrument corrected. The pulsed source was a Nano-LED con-
figured for 372 or 459 nm output operating at 500 kHz. Lumi-
nescence lifetime profiles were obtained using the JobinYvon–
Horiba FluoroHub single photon counting module and the
data fits yielded the lifetime values using the provided DAS6
deconvolution software. Electrochemical studies were carried
out using a Parstat 2273 potentiostat in conjunction with a
three-electrode cell. The auxiliary electrode was a platinum
wire and the working electrode a platinum (1.0 mm diameter)
disc. The reference was a silver wire separated from the test
solution by a fine porosity frit and an agar bridge saturated
with KCl. Solutions (10 ml CH2Cl2) were 1.0 × 10
−3 mol dm−3
in the test compound and 0.1 mol dm−3 in [NBun4][PF6] as the
supporting electrolyte. Under these conditions, E0, for the one-
electron oxidation of [Fe(η-C5H5)2] added to the test solutions
as an internal calibrant, is +0.46 V in CH2Cl2.
27 Unless speci-
fied, all electrochemical values are at υ = 200 mV s−1. Micro-
analyses were performed by London Metropolitan University,
UK.
Data collection and processing
Diﬀraction data for 3b and 3e were collected on a Nonius Kappa-
CCD using graphite-monochromated Mo-Kα radiation (λ =
0.71073 Å) at 150 K. Software package Apex 2 (v2.1) was used for
the data integration, scaling and absorption correction.
Structure analysis and refinement
The structure was solved by direct methods using SHELXS-97
and was completed by iterative cycles of ΔF-syntheses and full-
matrix least squares refinement. All non-H atoms were refined
anisotropically and diﬀerence Fourier syntheses were
employed in positioning idealised hydrogen atoms and were
allowed to ride on their parent C-atoms. All refinements were
against F 2 and used SHELX-97.28 CCDC reference numbers
907280 and 907282 contain the supplementary crystallo-
graphic data for this paper.
Fig. 5 Normalised luminescence emission spectra of 4g in various solvents
(5 × 10−5 M).
Table 4 Photophysical properties of [Ir(pqca)2(N^N)]Cl (4a–g) complexes
a
CH3CN H2O CH3OH
Complex λem/nm τ/ns λem/nm τ/ns λem/nm τ/ns
4a 569 211 592 261 583 414
4b 572 320 594 223 586 383
4c 574 258 589 190 582 385
4d 574 439 590 201 584 446
4e 577 322 608 619 585 370
4f 631 174 630 58 630 82
4g 568 113 598 199 584 297
a λex = 459 nm.
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DFT studies
DFT geometry optimisation and orbital calculations were per-
formed on the Gaussian 03 program.29 Geometry optimis-
ations were carried out without constraints using the B3PW91
functional. The LANL2DZ30 basis set was used for the Ir
centers, and was invoked with pseudo-potentials for the core
electrons, a 6-31G(d,p)31 basis set for all coordinating atoms
with a 6-31G32 basis set for all remaining atoms. All optimis-
ations were followed by frequency calculations to ascertain the
nature of the stationary point (minimum or saddle point).
TD-DFT studies were performed in Gaussian0933 using the
same functional, but with 6-31G(d) on all non-metal atoms,
and also included a simulated MeCN or H2O environment
using the polarised continuum model (PCM) approach.34 For
prediction of absorption spectra, the geometry used to calcu-
late orbital and other properties was used without modifi-
cation. For prediction of emission, however, the triplet state
was allowed to relax to its optimal geometry using unrestricted
B3PW91 in the gas phase, prior to solvated TD-DFT.
Synthesis
The ligands ethyl 2-phenylquinoline-4-carboxylate (epqcH) 1,35
dipyrido[3,2-a:2′,3′-c]phenazine (dppz),36 benzo[i]dipyrido[3,2-
a:2′,3′-c]phenazine (dppn)37 and naphtha[2,3-a]dipyrido[3,2-
h:2′,3′-f ]phenazine-5,18-dione (qdppz)38 were prepared accord-
ing to reported procedures.
[Ir(epqc)2(µ-Cl)2Ir(epqc)2] 2 was prepared by variation of the
standard literature procedures for other bridged-chloride
dimers.19 Thus, IrCl3·3H2O (0.266 g, 0.75 mmol) and epqcH
(0.520 g, 2.02 mmol) in 2-methoxyethanol–water (3 : 1, 8 ml)
were heated at reflux for 48 h. Water (25 ml) was added to give
a dark purple precipitate, which was filtered and dried in
vacuo. The product was used in subsequent reaction without
further purification.24
[Ir(epqc)2(bpy)]PF6 3a. [(epqc)2Ir(μ-Cl)2Ir(epqc)2] 2 (0.061 g,
0.04 mmol) and 2,2′-bipyridine (0.013 g, 0.08 mmol) in
2-methoxyethanol (5 ml) were heated at 120 °C for 16 h. The
solvent was then removed in vacuo and the crude product dis-
solved in MeCN (4 ml). KPF6 (1.05 g, 5.705 mmol) in water
(2 ml) was added and the solution stirred for 10 min. Water
(20 ml) was added and the product extracted with CH2Cl2 (2 ×
20 ml). The combined organic phases were washed with water
(30 ml) and brine (30 ml) before being dried over MgSO4. The
solution was filtered and the solvent removed in vacuo. The
crude product was then purified by column chromatography
(silica, CH2Cl2). After elution of unreacted organics with
CH2Cl2 the product was eluted as the first red fraction with
CH2Cl2–MeOH (9 : 1). The product was concentrated in volume
(to ca. 3 ml) and precipitated by the slow addition of Et2O
(5 ml) and dried in vacuo. Yield = 0.055 g, 76%. 1H NMR
(250 MHz, CDCl3) δH = 8.51 (2H, s), 8.42 (2H, d,
3JHH = 5.8 Hz),
8.23 (2H, d, 3JHH = 7.5 Hz), 8.05–7.8 (6H, m), 7.70–7.35 (6H,
m), 7.21 (2H, app. t, 3JHH = 7.6 Hz), 7.02 (2H, app. t,
3JHH = 7.5
Hz), 6.86 (2H, app. t, 3JHH = 7.6 Hz), 6.53 (2H, d,
3JHH = 7.6
Hz), 4.50 (4H, m), 1.52 (6H, m) ppm. 13C–{1H} NMR (75 MHz,
CDCl3) δC = 169.6, 166.4, 156.9, 148.7, 147.4, 145.0, 140.2,
138.3, 131.6, 130.4, 130.1, 129.1, 128.1, 127.8, 126.9, 125.5,
125.1, 124.1, 123.5, 120.6, 116.6, 62.2, 14.4 ppm. UV-vis
(MeCN): λmax (ε/dm
3 mol−1 cm−1) 470 (4500), 350 (22 000), 292
(39 500), 268 (45 650) nm. Elemental analysis: Calcd (%) for
C46H36N4O4IrPF6: C, 52.82, H, 3.47, N, 5.36; Found: C, 52.90,
H, 3.48, N, 5.36. ES MS found m/z 901.3, calculated m/z 901.0
for [M − PF6]+. HR MS found m/z 901.2370, calculated m/z
901.2363 for [C46H36N4O4
191Ir]+. IR (solid): ν 1722 (CO), 837
(PF6
−) cm−1.
[Ir(epqc)2(dmbpy)]PF6 3b. Prepared similarly from 2
(0.069 g, 0.037 mmol) and 4-4′-dimethyl-2,2′-bipyridine
(dmbpy) (0.0136 g, 0.074 mmol). Yield = 0.058 g, 85%. 1H
NMR (250 MHz, CDCl3) δH = 8.51 (2H, s), 8.47 (2H, d,
3JHH =
7.9 Hz), 8.01–7.81 (4H, m), 7.72 (2H, d, 3JHH = 7.9 Hz),
7.52–7.31 (4H, m), 7.2–7.0 (4H, m), 6.95 (2H, app. t, 3JHH = 8.5
Hz). 6.83 (2H, app. t, 3JHH = 7.3 Hz), 6.50 (2H, d,
3JHH = 7.3
Hz), 4.62 (4H, q, 3JHH = 7.1 Hz), 2.47 (6H, s), 1.56 (6H, t,
3JHH =
7.2 Hz) ppm. 13C–{1H} NMR (75 MHz, CDCl3) δC = 169.7, 165.2,
155.2, 152.7, 148.9, 146.6, 145.1, 138.7, 134.8, 131.5, 129.8,
129.5, 128.8, 127.6, 127.2, 126.4, 125.3, 123.3, 122.4, 120.2,
118.6, 65.9, 21.3, 15.4 ppm. UV-vis (MeCN): λmax (ε/dm
3 mol−1
cm−1) 467 (4200), 350 (23 500), 290 (46 500), 265 (55 300) nm.
Elemental analysis: Calcd (%) for C48H40N4O4IrPF6: C, 53.68,
H, 3.75, N, 5.22; Found: C, 53.86, H, 3.79, N, 5.26. ES MS
found m/z 929.3, calculated m/z 929.3 for [M − PF6]+. HR MS
found m/z 927.2650, calculated m/z 927.2650 for
[C48H40N4O4
191Ir]+. IR (solid): ν 1720 (CO), 829 (PF6
−) cm−1.
[Ir(epqc)2(dmbpc)]PF6 3c. Prepared similarly from 2
(0.069 g, 0.049 mmol) and diethyl-2,2′-bipyridine-4,4′-dicarboxy-
late (0.028 g, 0.098 mmol). Yield = 0.072 g, 74%. 1H NMR
(250 MHz, CDCl3) δH = 8.67 (2H, d,
3JHH = 7.5 Hz), 8.58 (2H, d,
3JHH = 7.6 Hz), 8.43–8.34 (2H, m), 8.16–8.05 (4H, m), 7.55 (2H,
d, 3JHH = 7.5 Hz), 7.45 (2H, app. t,
3JHH = 8.7 Hz), 7.35–7.19
(4H, m), 7.08 (2H, app. t, 3JHH = 8.7 Hz), 6.88 (2H, app. t,
3JHH
= 7.6 Hz), 6.51 (2H, d, 3JHH = 7.6 Hz), 4.52 (4H, q,
3JHH = 7.2
Hz), 4.46 (4H, br t), 3.68 (4H, br t), 3.30 (6H, s), 1.48 (6H, t,
3JHH = 7.2 Hz) ppm.
13C–{1H} NMR (75 MHz, CDCl3) δC =
169.6, 166.4, 162.9, 156.7, 150.1, 148.4, 147.1, 144.9, 140.7,
139.0, 134.8, 131.6, 130.0, 129.0, 127.7, 127.1, 124.9, 124.0,
123.2, 120.5, 118.8, 116.6, 70.3, 65.6, 62.9, 61.9, 15.2 ppm. UV-
vis (MeCN): λmax (ε/dm
3 mol−1 cm−1) 464 (2900), 352 (18 200),
291 (39 500), 267 (47 900) nm. Elemental analysis: Calcd (%)
for C54H48N4O10IrPF6: C, 51.88, H, 3.87, N, 4.48; Found: C,
51.74, H, 3.84, N, 4.46. ES MS found m/z 1105.3, calculated m/z
1105.2 for [M − PF6]+. HR MS found m/z 1105.2977, calculated
m/z 1103.2977 for [C54H48N4O10
191Ir]+. IR (solid): ν 1724 (CO),
835 (PF6
−) cm−1.
[Ir(epqc)2(phen)]PF6 3d. Prepared similarly from 2 (0.064 g,
0.041 mmol) and 1,10-phenanthroline monohydrate (0.015 g,
0.082 mmol). Yield = 0.060 g, 82%. 1H NMR (250 MHz, CDCl3)
δH = 8.66 (2H, d,
3JHH = 7.6 Hz), 8.52–8.36 (4H, m), 8.23 (2H, d,
3JHH = 7.6 Hz), 8.16 (2H, d,
3JHH = 7.5 Hz), 7.92–7.77 (4H, m),
7.70–7.51 (4H, m), 7.33 (2H, d, 3JHH = 8.2 Hz), 6.90 (2H, app. t,
3JHH = 7.6 Hz), 6.80 (2H, app. t,
3JHH = 7.6 Hz), 6.63 (2H, d,
3JHH = 7.5 Hz), 4.58 (4H, q,
3JHH = 7.3 Hz), 1.53 (6H, t,
3JHH =
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7.3 Hz) ppm. 13C–{1H} NMR (75 MHz, CDCl3) δC = 169.6, 164.9,
156.9, 149.6, 148.9, 147.9, 144.6, 138.6, 136.9, 135.0, 130.7,
130.0, 129.7, 128.8, 127.7, 127.4, 126.6, 125.2, 124.3, 123.5,
120.3, 118.6, 62.0, 14.1 ppm. UV-vis (MeCN): λmax (ε/dm
3 mol−1
cm−1) 460 (4500), 356 (25 800), 288 (52 800), 269 (65 400) nm.
Elemental analysis: Calcd (%) for C48H36N4O4IrPF6: C, 53.88,
H, 3.39, N, 5.24; Found: C, 53.75, H, 3.51, N, 5.28. ES MS
found m/z 925.2, calculated m/z 925.2 for [M − PF6]+. HR MS
found m/z 923.2345, calculated m/z 923.2337 for
[C48H36N4O4
191Ir]+. IR (solid): ν 1722 (CO), 833 (PF6
−) cm−1.
[Ir(epqc)2(dip)]PF6 3e. Prepared similarly from 2 (0.060 g,
0.037 mmol) and 4,7-diphenyl-1,10-phenanthroline (0.025 g,
0.074 mmol). Yield = 0.060 g, 78%. 1H NMR (250 MHz, CDCl3)
δH = 8.61 (2H, s), 8.51 (2H, d,
3JHH = 5.6 Hz), 8.48 (2H, d,
3JHH =
8.2 Hz), 8.16 (4H, d, 3JHH = 7.5 Hz), 7.81 (2H, s), 7.78 (2H, d,
3JHH = 5.6 Hz), 7.51–7.34 (10H, m), 7.38–7.28 (4H, m), 6.9–6.75
(4H, m), 6.61 (2H, d, 3JHH = 7.5 Hz), 4.60 (4H, q,
3JHH = 7.1 Hz),
1.55 (6H, t, 3JHH = 7.1 Hz) ppm.
13C–{1H} NMR (75 MHz,
CDCl3) δC = 170.0, 165.2, 156.7, 151.3, 148.6, 147.2, 145.3,
138.8, 135.2, 131.6, 130.9, 130.1, 129.9, 129.3, 128.7, 128.2,
127.9, 126.9, 126.7, 126.0, 125.6, 124.8, 124.4, 123.8, 120.5,
119.1, 63.0, 14.4 ppm. UV-vis (MeCN): λmax (ε/dm
3 mol−1 cm−1)
465 (3600), 344 (23 300), 290 (55 900), 269 (59 000) nm.
Elemental analysis: Calcd (%) for C60H44N4O4IrPF6: C, 58.96,
H, 3.63, N, 4.58; Found: C, 58.90, H, 3.57, N, 4.54. ES MS
found m/z 1077.3, calculated m/z 1077.2 for [M − PF6]+. HR MS
found m/z 1075.2947, calculated m/z 1075.2963 for
[C60H44N4O4
191Ir]+. IR (solid): ν 1721 (CO), 835 (PF6
−) cm−1.
[Ir(epqc)2(dppz)]PF6 3f. Prepared similarly from 2 (0.072 g,
0.046 mmol) and dppz (0.028 g, 0.099 mmol). Yield = 0.081 g,
75%. 1H NMR (250 MHz, CDCl3) δH = 9.46 (1H, d,
3JHH =
8.0 Hz), 9.39 (1H, d, 3JHH = 8.1 Hz), 9.14 (1H, br s), 8.62–8.55 (2H,
m), 8.46 (1H, d, 3JHH = 4.8 Hz), 8.30 (1H, app. t,
3JHH = 4.1 Hz),
8.20–7.90 (4H, m), 7.85 (2H, app. t, 3JHH = 6.7 Hz), 7.80–7.75
(2H, m), 7.71–7.61 (2H, m), 7.49–7.42 (2H, m), 7.30–7.23 (4H,
m), 7.16–7.06 (2H, m), 6.80 (2H, app. t, 3JHH = 7.7 Hz), 6.56
(1H, d, 3JHH = 7.6 Hz), 4.46 (4H, q,
3JHH = 7.1 Hz), 1.55 (6H, t,
3JHH = 7.1 Hz) ppm.
13C–{1H} NMR (75 MHz, CDCl3) δC =
169.7, 164.8, 156.3, 152.1, 149.6, 148.7, 148.3, 145.2, 142.8,
138.9, 138.6, 136.0, 135.1, 132.4, 131.5, 130.4, 129.5, 128.6,
127.9, 127.3, 126.8, 124.5, 123.8, 118.9, 62.9, 14.2 ppm. UV-vis
(MeCN): λmax (ε/dm
3 mol−1 cm−1) 463 (3600), 364 (29 700),
272 (82 600) nm. Elemental analysis: Calcd (%) for
C54H38N6O4IrPF6: C, 55.34, H, 3.27, N, 7.17; Found: C, 55.42,
H, 3.33, N, 7.08. ES MS found m/z 1027.3, calculated m/z
1027.3 for [M − PF6]+. HR MS found m/z 1025.2561, calculated
m/z 1025.2555 for [C54H38N6O4
191Ir]+. IR (solid): ν 1724 (CO),
830 (PF6
−) cm−1.
[Ir(epqc)2(dppn)]PF6 3g. Prepared similarly from 2 (0.064 g,
0.041 mmol) and dppn (0.028 g, 0.084 mmol). Yield = 0.078 g,
78%. 1H NMR (250 MHz, CDCl3) δH = 9.43 (1H, d,
3JHH = 8.2
Hz), 8.92 (1H, br s), 8.76 (1H, s), 8.66 (2H, app. t, 3JHH = 4.8
Hz), 8.55 (1H, d, 3JHH = 4.8 Hz), 8.48–8.41 (2H, m), 8.38–8.31
(2H, m), 8.22 (1H, d, 3JHH = 6.7 Hz), 8.14–8.06 (2H, m),
8.03–7.94 (2H, m), 7.55–7.16 (7H, m), 7.10–6.95 (3H, m),
6.92–6.80 (3H, m), 6.71–6.54 (2H, m), 4.50 (4H, q, 3JHH =
7.1 Hz), 1.48 (6H, t, 3JHH = 7.1 Hz) ppm.
13C–{1H} NMR (75 MHz,
CDCl3) δC = 170.2, 165.0, 150.5, 149.8, 148.7, 148.5, 145.2,
138.9, 138.4, 136.5, 136.0, 135.2, 133.7, 131.8, 131.3, 130.0,
129.0, 128.8, 128.2, 128.1, 127.6, 127.1, 126.7, 125.3, 124.7,
124.0, 119.6, 63.0, 14.4 ppm. UV-vis (MeCN): λmax (ε/dm
3 mol−1
cm−1) 461 (5400), 416 (12 100), 398 (13 500), 327 (58 600), 292
(51 900), 266 (68 200) nm. Elemental analysis: Calcd (%) for
C58H40N6O4IrPF6: C, 57.00, H, 3.30, N, 6.88; Found: C, 57.01,
H, 3.34, N, 6.76. ES MS found m/z 1077.2, calculated m/z
1077.3 for [M − PF6]+. HR MS found m/z 1075.2715, calculated
m/z 1075.2711 for [C58H40N6O4
191Ir]+. IR (solid): ν 1719 (CO),
828 (PF6
−) cm−1.
[Ir(epqc)2(qdppz)]PF6 3h. Prepared similarly from 2
(0.068 g, 0.044 mmol) and qdppz (0.037 g, 0.090 mmol). Yield
= 0.094 g, 83%. 1H NMR (250 MHz, CDCl3) δH = 9.38 (2H, d,
3JHH = 5.1 Hz), 8.64 (2H, s), 8.61 (2H, d,
3JHH = 5.0 Hz), 8.34
(2H, dd, 3JHH = 8.6 and 4.1 Hz), 8.13 (2H, app. t,
3JHH = 6.90
Hz), 8.07–7.92 (3H, m), 7.70 (2H, app. t, 3JHH = 8.9 Hz), 7.56
(1H, d, 3JHH = 7.1 Hz), 7.44 (1H, app. t,
3JHH = 7.1 Hz), 7.38
(2H, app. t, 3JHH = 7.9 Hz), 7.28 (1H, app. t,
3JHH = 7.4 Hz), 7.19
(2H, app. t, 3JHH = 7.6 Hz), 7.15–7.02 (2H, m), 6.94 (2H, app. t,
3JHH = 7.5 Hz), 6.86 (2H, app. t,
3JHH = 7.3 Hz), 6.62 (2H, app. t,
3JHH = 5.74 Hz), 4.50 (4H, q,
3JHH = 7.2 Hz), 1.42 (6H, t,
3JHH =
7.2 Hz) ppm. 13C–{1H} NMR (75 MHz, CDCl3) δC = 166.4, 156.7,
148.9, 138.5, 136.5, 130.2, 130.0, 129.0, 127.9, 127.6, 125.5,
124.1, 120.4, 120.3, 116.5, 62.1, 14.4 ppm. UV-vis (MeCN): λmax
(ε/dm3 mol−1 cm−1) 460 (4550), 367 (29 500), 278 (83 750),
212 (85 650) nm. Elemental analysis: Calcd (%) for
C62H40N6O6IrPF6: C, 57.19, H, 3.10, N, 6.45; Found: C, 57.12,
H, 3.18, N, 6.40. ES MS found m/z 1157.3, calculated m/z
1157.2 for [M − PF6]+. HR MS found m/z 1155.2587, calculated
m/z 1155.2610 for [C62H40N6O6
191Ir]+. IR (solid): ν 1722 (CO),
1610 (CO), 832 (PF6
−) cm−1.
[Ir(pqca)2(bpy)]Cl 4a. Complex 3a (0.036 g, 0.020 mmol) was
dissolved in acetone (5 ml) and KOH (1 M soln, 5 ml) added.
The mixture was stirred at room temp. for 14 h. The solvent
was removed in vacuo and water (20 ml) added, followed by
neutralisation with HCl (1 M soln). Water was removed in
vacuo and product was dissolved in MeOH (10 ml). The solu-
tion was filtered to remove salts and the solvent removed in
vacuo. Yield = 0.022 g, 65%. 1H NMR (400 MHz, MeOD) δH =
8.37 (2H, s), 8.20–8.15 (4H, m), 8.12 (2H, d, 3JHH = 7.7 Hz), 8.06
(2H, d, 3JHH = 7.7 Hz), 7.89 (2H, app. t,
3JHH = 8.0 Hz), 7.44
(2H, app. t, 3JHH = 7.3 Hz), 7.30 (2H, d,
3JHH = 7.6 Hz), 7.23
(2H, app. t, 3JHH = 7.5 Hz), 7.03 (2H, app. t,
3JHH = 7.7 Hz), 6.87
(2H, app. t, 3JHH = 7.7 Hz), 6.69 (2H, app. t,
3JHH = 7.4 Hz), 6.53
(2H, d, 3JHH = 7.7 Hz) ppm. UV-vis (MeOH): λmax (ε/dm
3 mol−1
cm−1) 453, (1200), 333 (11 200), 285 (12 350) nm. ES MS found
m/z 845.1, calculated m/z 844.9 for [M − Cl]+. HR MS found
m/z 843.1710, calculated m/z 843.1711 for [C42H28N4O4
191Ir]+.
IR (solid): ν 1578 (CO) cm−1.
[Ir(pqca)2(dmbpy)]Cl 4b. Prepared similarly from 3b
(0.050 g, 0.088 mmol). Yield = 0.041 g, 80%. 1H NMR
(250 MHz, MeOD) δH = 8.67 (2H, s), 8.70 (2H, d,
3JHH = 5.8 Hz),
8.46 (2H, d, 3JHH = 8.2 Hz), 8.29 (2H, d,
3JHH = 8.2 Hz), 8.19
(2H, d, 3JHH = 7.6 Hz), 7.98 (2H, s), 7.95 (2H, app. t,
3JHH =
Paper Dalton Transactions
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6.2 Hz), 7.73 (2H, app. t, 3JHH = 7.0 Hz), 7.44 (2H, d,
3JHH = 8.4
Hz), 7.27 (2H, app. t, 3JHH = 7.6 Hz), 6.82 (2H, app. t,
3JHH = 7.1
Hz), 6.67 (2H, d, 3JHH = 7.6 Hz), 2.57 (6H, s) ppm.
13C–{1H}
NMR (75 MHz, MeOD) δC = 171.1, 155.5, 1519, 151.2, 147.9,
147.0, 146.2, 134.4, 130.2, 129.6, 129.3, 128.6, 127.6, 127.4,
126.9, 126.2, 125.0, 124.5, 124.3, 122.6, 114.3, 19.8 ppm. UV-vis
(MeOH): λmax (ε/dm
3 mol−1 cm−1) 450 (1600), 341 (6000), 286
(16 800), 267 (18 600) nm. ES MS found m/z 873.2, calculated
m/z 873.0 for [M − Cl]+. HR MS found m/z 871.2018, calculated
m/z 871.2024 for [C44H32N4O4
191Ir]+. IR (solid): ν 1578 (CO) cm−1.
[Ir(pqca)2(bpdc)]Cl 4c. Prepared similarly from 3c (0.055 g,
0.053 mmol). Yield = 0.044 g, 91%. 1H NMR (250 MHz, MeOD)
δH = 8.68 (2H, br s), 8.38 (2H, s), 8.27 (2H, d,
3JHH = 5.7 Hz),
8.19 (2H, app. t, 3JHH = 9.1 Hz), 7.92 (2H, s), 7.90 (2H, d,
3JHH =
5.7 Hz), 7.43–7.31 (4H, m), 7.17 (2H, app. t, 3JHH = 7.7 Hz),
6.98 (2H, app. t, 3JHH = 7.9 Hz), 6.80 (2H, app. t,
3JHH = 7.1 Hz),
6.53 (2H, d, 3JHH = 7.2 Hz) ppm.
13C–{1H} NMR (75 MHz,
MeOD) δC = 172.2, 170.4, 160.4, 157.8, 151.0, 150.7, 148.1,
147.2, 146.3, 139.3, 135.4, 134.7, 130.3, 129.9, 129.6, 128.8,
128.6, 127.5, 127.0, 126.7, 126.3, 125.5, 124.4, 122.8, 116.5,
114.5 ppm. UV-vis (MeOH): λmax (ε/dm
3 mol−1 cm−1) 449
(1300), 338 (5000), 287 (15 700), 262 (20 400) nm. ES MS found
m/z 933.1, calculated m/z 932.9 for [M − Cl]+. HR MS found
m/z 931.1507, calculated m/z 931.1508 for [C44H28N4O8
191Ir]+.
IR (solid): ν 1578 (CO) cm−1.
[Ir(pqca)2(phen)]Cl 4d. Prepared similarly from 3d (0.040 g,
0.043 mmol). Yield = 0.026 g, 70%. 1H NMR (400 MHz, MeOD)
δH = 8.81 (2H, s), 8.62 (2H, d,
3JHH = 5.8 Hz), 8.46 (2H, app. t,
3JHH = 8.2 Hz), 8.29 (2H, d,
3JHH = 8.2 Hz), 8.19 (2H, d,
3JHH =
7.6 Hz), 7.98 (2H, s), 7.95 (2H, app. t, 3JHH = 6.2 Hz), 7.73 (2H,
app. t, 3JHH = 7.0 Hz), 7.44 (2H, d,
3JHH = 8.4 Hz), 7.27 (2H,
app. t, 3JHH = 7.6 Hz), 6.91 (2H, app. t,
3JHH = 7.4 Hz), 6.82 (2H,
app. t, 3JHH = 7.1 Hz), 6.67 (2H, d,
3JHH = 7.6 Hz) ppm. UV-vis
(MeOH): λmax (ε/dm
3 mol−1 cm−1) 445 (2600), 339 (11 000), 266
(37 400) nm. ES MS found m/z 869.1, calculated m/z 868.9 for
[M − Cl]+. HR MS found m/z 867.1704, calculated m/z 867.1711
for [C44H28N4O4
191Ir]+. IR (solid): ν 1597 (CO) cm−1.
[Ir(pqca)2(dip)]Cl 4e. Prepared similarly from 3e (0.030 g,
0.024 mmol). Yield 0.018 g, 76%. 1H NMR (400 MHz, MeOD)
δH = 8.84 (2H, s), 8.69 (2H, d,
3JHH = 7.6 Hz), 8.53 (2H, d,
3JHH =
7.8 Hz), 8.31 (2H, d, 3JHH = 7.6 Hz), 7.93 (4H, app. t,
3JHH = 7.2
Hz), 7.59–7.49 (12H, m), 7.35 (2H, app. t, 3JHH = 6.2 Hz), 7.28
(2H, app. t, 3JHH = 6.8 Hz), 6.98–6.88 (4H, m), 6.71 (2H, d,
3JHH
= 7.8 Hz) ppm. 13C–{1H} NMR (75 MHz, MeOD) δC = 172.2,
170.1, 151.0, 150.9, 150.7, 148.1, 147.2, 146.3, 135.4, 134.7,
130.3, 130.0, 129.7, 129.6, 128.8, 128.6, 128.5, 127.5, 127.4,
127.0, 126.7, 126.3, 125.5, 124.4, 122.8, 116.5, 114.5 ppm. UV-
vis (MeOH): λmax (ε/dm
3 mol−1 cm−1) 448 (1700), 402 (1400),
336 (7900), 288 (22 400), 266 (22 600) nm. ES MS found m/z
1021.2, calculated m/z 1021.1 for [M − Cl]+. HR MS found m/z
1019.2333, calculated m/z 1019.2337 for [C56H36N4O4
191Ir]+.
IR (solid): ν 1576 (CO) cm−1.
[Ir(pqca)2(dppz)]Cl 4f. Prepared similarly from 3f (0.052 g,
0.044 mmol). Yield 0.035 g, 79%. 1H NMR (400 MHz, MeOD)
δH = 9.48 (2H, d,
3JHH = 7.6 Hz), 8.74 (2H, s), 8.62 (2H, d,
3JHH =
5.0 Hz), 8.38–8.30 (2H, m), 8.22 (2H, d, 3JHH = 7.9 Hz),
8.13–8.05 (3H, m), 7.98 (2H, app t), 7.87 (2H, br d), 7.75 (1H,
app. t), 7.59 (1H, app. t), 7.50–7.40 (3H, m), 7.21–7.12 (2H, m),
6.88–6.80 (2H, m), 6.61 (2H, d, 3JHH = 7.6 Hz) ppm. UV-vis
(MeOH): λmax (ε/dm
3 mol−1 cm−1) 435 (1800), 335 (9000), 289
(18 400), 265 (23 400) nm. HR MS found m/z 969.1914, calcu-
lated m/z 969.1929 for [C50H30N6O4
191Ir]+. IR (solid): ν 1575
(CO) cm−1.
[Ir(pqca)2(dppn)]Cl 4g. Prepared similarly from 3g (0.048 g,
0.039 mmol). Yield 0.029 g, 71%. 1H NMR (400 MHz, MeOD)
δH = 9.49 (2H, d,
3JHH = 7.6 Hz), 8.80 (2H, s), 8.61 (2H, dd, JHH
= 5.3 and 1.4 Hz), 8.34–8.28 (4H, m), 8.20–7.85 (4H, overlap-
ping m), 7.51–7.38 (5H, m), 7.33 (2H, d, 3JHH = 7.6 Hz),
7.18–7.05 (3H, m), 6.81–6.70 (4H, m), 6.60 (2H, d, 3JHH = 7.7
Hz) ppm. UV-vis (MeOH): λmax (ε/dm
3 mol−1 cm−1) 429 (2600),
330 (17 700), 287 (24 200), 263 (33 800) nm. HR MS found m/z
1019.2089, calculated m/z 1019.2085 for [C54H32N6O4
191Ir]+. IR
(solid): ν 1578 (CO) cm−1.
Conclusions
Water-soluble, luminescent iridium(III) complexes can be con-
veniently synthesised through the use of cinchophen-based
ligands. The Ir(III) coordination chemistry of ethyl-2-phenylqui-
noline-4-carboxylate can be achieved using traditional
methods and the resultant cyclometalated complexes are toler-
ant to the subsequent deprotection strategy. The new com-
plexes of the form [Ir(pqca)2(N^N)]
+ are luminescent via an
excited state that is best described as possessing substantial
3MLCT character; the CT nature was reflected in the solvent-
sensitive properties of the complexes. TD-DFT calculations also
revealed that careful modelling of the protonated form of the
carboxylic acid/carboxylate is necessary to allow a more precise
approximation of the electronic characteristics of the complexes.
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